Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A
Clinical trial NCT03766763 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03766763
- Sponsor
- French Innovative Leukemia Organisation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-22
- Primary completion
- 2022-01-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.